Navigenics, Inc. develops and commercializes genetics-based products and services to improve individual health and wellness. Navigenics educates and empowers individuals and their physicians by providing clinically actionable, personalized genetic insights about disease risk and medication response to catalyze behavior change and inform clinical decision-making. The company was founded by leading scientists and clinicians, and continues to advance genomic knowledge and adoption of molecular medicine through studies with leading academic centers. Navigenics’ services are available through employer wellness programs and health plans, as well as through physicians and medical centers. Among Navigenics’ investors are Kleiner Perkins Caulfield and Byers, Mohr Davidow Ventures and The Procter & Gamble Company.
Specialties
personal genomics, personalized health, genetic testing, genetic analysis, DNA testing, personalized medicine, genetic counselor, genetic counseling
